Presentation
5 March 2021 Design and testing of fluorescence-guided endoscopic biopsy assessment at the bedside
Author Affiliations +
Abstract
Clinical detection of premalignant lesions often requires labeling with molecular probes. In the gastrointestinal tract, most cancers originate in epithelial layers which are interrogated using topically-applied probes with conjugated fluorescence dyes. As part of clinical trials using fluorescence peptide probes, we have developed two different instruments that rapidly image the biopsy at the bedside before fixation. These multimodal images (visible light reflectance and near infrared fluorescence) provide verification that the targeted lesion was sampled, and provide feedback to the clinician at the bedside for any follow-up procedure. Performance of these two prototypes are compared for fluorescence sensitivity and multimodal image quality.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mark E. Fauver, Yang Jiang, Matthew D. Carson, Sean X. Gui, and Eric J. Seibel "Design and testing of fluorescence-guided endoscopic biopsy assessment at the bedside", Proc. SPIE 11633, Design and Quality for Biomedical Technologies XIV, 116330H (5 March 2021); https://doi.org/10.1117/12.2579374
Advertisement
Advertisement
KEYWORDS
Biopsy

Luminescence

Endoscopy

Prototyping

Near infrared

Pathology

Point-of-care devices

Back to Top